NEG 发表于 2025-3-23 13:34:00
http://reply.papertrans.cn/23/2211/221065/221065_11.pngPainstaking 发表于 2025-3-23 17:35:56
Cell-Internalization , of RNA Aptamers as a Starting Point for Prostate Cancer Research instead DNA aptamers allows to obtain aptamers that are internalized in prostate cancer cells using as a starting point an RNA aptamer library with 76 nucleotides. The major advantage of this technique is that modifications are not required in the initial library, as initial T7 transcription promoter or 2′F nucleotides before sequencing.Asseverate 发表于 2025-3-23 19:01:30
Book 2021Latest editionding known pitfalls. .Authoritative and timely, .Cancer Cell Signaling: Methods and Protocols, Third Edition. serves as an ideal guide to researchers seeking to overcome the challenges in the vital field of cancer cell signaling..musicologist 发表于 2025-3-23 22:54:58
Chikako Tanaka,Patrick L. McGeer,Yasuo Iharand the energetic consequences of such an approach. In this chapter, by using the CT26.WT murine colon adenocarcinoma cell line as a model of study, we provide a method to simultaneously perform a pharmacological blockade of tumor anabolism and host catabolism, as a feasible therapeutic approach to treat cancer, and to limit its energetic supply.Flawless 发表于 2025-3-24 03:46:02
Movimento, atto motorio e azione, tumor cells to classify response in HNSCC as part of a prospective trial (PREDICT-HN). An adaption of the methodology from that trial is described herein in hopes of allowing for recapitulation and further development of this exciting methodology.Feigned 发表于 2025-3-24 09:19:30
http://reply.papertrans.cn/23/2211/221065/221065_16.pngBACLE 发表于 2025-3-24 12:51:51
http://reply.papertrans.cn/23/2211/221065/221065_17.png无能的人 发表于 2025-3-24 15:53:17
http://reply.papertrans.cn/23/2211/221065/221065_18.pngMIRE 发表于 2025-3-24 23:02:32
http://reply.papertrans.cn/23/2211/221065/221065_19.png胰岛素 发表于 2025-3-25 01:28:14
Reverse Docking for the Identification of Molecular Targets of Anticancer Compoundsn (4-HC). Our results showed that RAC1 is a target of 4-HC, which partially explains the biological activities of 4-HC on cancer cells. The strategy reported here can be easily applied to other compounds and protein datasets.